MMRGlobal Announces Final Settlement Conference and Jury Trial Dates in MyMedicalRecords Patent Litigation

LOS ANGELES, CA--(Marketwired - Sep 22, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), announced today that a Post-Markman Scheduling Order was entered by the United States District Court, Central District of California on September 19, 2014 in plaintiff MyMedicalRecords patent infringement cases against defendants Quest Diagnostics, Inc., Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. & WebMD Health Services Group, Inc. MyMedicalRecords is pleased that the Court denied Defendants' request to stay discovery and instead opened discovery through 2/18/2015, also setting a last date to conduct settlement conferences of 3/18/2015 and a Jury Trial starting 5/19/2015. A complete copy of the comprehensive scheduling order leading to trial can be found on PACER at http://www.pacer.gov/.

The Company also commented that MMR shareholders can now look forward to obtaining a prompt determination on the merits of MMR's patent claims through a jury trial.

John Fuisz, co-founder of The Fuisz-Kundu Group and an attorney for MyMedicalRecords, said, "MMR is pleased the Court denied Defendants' request to stay discovery and instead opened discovery and set a comprehensive schedule leading to a trial date. We look forward to taking discovery and getting to trial on the merits of MMR's patent infringement claim."

MyMedicalRecords, Inc. is a practicing entity and a leading provider of secure and easy-to-use Personal Health Records through its MyMedicalRecords PHR, and MMRPro document management and imaging systems for healthcare professionals. MMR also offers MyEsafeDepositBox, which provides an online site to securely store important legal, financial, insurance and other important documents, as well as medical and personal health information. MMR currently has 13 issued U.S. health IT patents including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. The most recently issued patent, U.S. Patent No. 8,775,212, represents MMR's first Clinical Trials patent and includes 18 claims directed to methods and systems that provide for self-reporting being used to create Electronic Health Records for purposes including Clinical Trials. In addition to the U.S., MMR currently has patents issued, pending and/or applied for in 11 other countries or regional authorities including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea, Israel and Europe.